Accès gratuit
Numéro
Réanimation
Volume 24, Numéro 1, Janvier 2015
Respiratoire
Page(s) 84 - 86
Section Letter to the Editor / Lettre À L’Éditeur
DOI https://doi.org/10.1007/s13546-014-1017-3
Publié en ligne 8 janvier 2015
  • Binder L, Pieske B, Olschewski M, et al (2005) N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 112:1573–1579 [CrossRef] [PubMed] [Google Scholar]
  • Kucher N, Printzen G, Goldhaber SZ (2003) Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 107:2545–2547 [CrossRef] [PubMed] [Google Scholar]
  • van der Meer RW, Pattynama PM, van Strijen MJ, et al (2005) Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism. Radiology 235:798–803 [CrossRef] [PubMed] [Google Scholar]
  • ten Wolde M, Söhne M, Quak E, Mac Gillavry MR, Büller HR (2004) Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. Arch Int Med 164:1685–1689 [CrossRef] [Google Scholar]
  • Goldhaber SZ, Kessler CM, Heit JA, et al (1992) Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. J Am Coll Cardiol 20:24–30 [CrossRef] [PubMed] [Google Scholar]
  • Konstantinides S, Geibel A, Heusel G, et al (2002) Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 347:1143–1150 [CrossRef] [PubMed] [Google Scholar]
  • Committee Steering (2012) Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: Rationale and design of the Pulmonary EmbolIsm THrOmbolysis (PEITHO) trial. The Steering Committee1. Am Heart J 163:33–38 [CrossRef] [PubMed] [Google Scholar]
  • Kline JA, Nordenholz KE, Courtney DM, et al (2014) Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial. J Thromb Haemost 12:459–468 [CrossRef] [PubMed] [Google Scholar]
  • Konstantinides SV, Torbicki A, Agnelli G, et al (2014) 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) endorsed by the European Respiratory Society (ERS). Eur Heart J 35:3033–3080 [CrossRef] [PubMed] [Google Scholar]
  • Mi YH, Liang Y, Lu YH, et al (2013) Recombinant tissue plasminogen activator plus heparin compared with heparin alone for patients with acute submassive pulmonary embolism. J Geriatr Cardiol 10:323–329 [PubMed] [Google Scholar]
  • Vieillard-Baron A, Page B, Augarde R, et al (2001) Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med 27:1481–1486 [CrossRef] [PubMed] [Google Scholar]
  • Rose PS, Punjabi NM, Pearse DB (2002) Treatment of right heart thromboemboli. Chest 121:806–814 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.